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Background: Normal colon crypts consist of stem cells, proliferating cells, and
differentiated cells. Abnormal rates of proliferation and differentiation can initiate
colon cancer. We have measured the variation in the number of each of these cell
types in multiple crypts in normal human biopsy specimens. This has provided the
opportunity to produce a calibrated computational model that simulates cell
dynamics in normal human crypts, and by changing model parameter values, to
simulate the initiation and treatment of colon cancer.
Results: An agent-based model of stochastic cell dynamics in human colon crypts
was developed in the multi-platform open-source application NetLogo. It was
assumed that each cell’s probability of proliferation and probability of death is
determined by its position in two gradients along the crypt axis, a divide gradient
and in a die gradient. A cell’s type is not intrinsic, but rather is determined by its
position in the divide gradient. Cell types are dynamic, plastic, and inter-convertible.
Parameter values were determined for the shape of each of the gradients, and for a
cell’s response to the gradients. This was done by parameter sweeps that indicated
the values that reproduced the measured number and variation of each cell type,
and produced quasi-stationary stochastic dynamics. The behavior of the model was
verified by its ability to reproduce the experimentally observed monocolonal
conversion by neutral drift, the formation of adenomas resulting from mutations
either at the top or bottom of the crypt, and by the robust ability of crypts to
recover from perturbation by cytotoxic agents. One use of the virtual crypt model
was demonstrated by evaluating different cancer chemotherapy and radiation
scheduling protocols.
Conclusions: A virtual crypt has been developed that simulates the quasi-stationary
stochastic cell dynamics of normal human colon crypts. It is unique in that it has
been calibrated with measurements of human biopsy specimens, and it can simulate
the variation of cell types in addition to the average number of each cell type. The
utility of the model was demonstrated with in silico experiments that evaluated
cancer therapy protocols. The model is available for others to conduct additional
experiments.
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Colon crypts are a paradigm of a dynamic biological system that maintains homeostasis.
Crypts contain several types of cells with transitions between cell types, and variation in
the number of each cell type. The transitions between cell types and the variation in the
number of each type of cell cannot be observed in vivo in real time, but have been inferred
from static histological images. Computer and mathematical models based on information
obtained from these static images and from molecular cell biology experiments have pro-
vided insights into these dynamic processes.Biology of crypts
Crypts are invaginations of the lumen of the large intestine (colon) and of the small in-
testine. The crypts of the colon function to absorb water and exchange electrolytes
from the feces, and to produce mucus to lubricate feces as they move through the
colon [1]. Each human crypt contains several thousand cells arranged in the form of a
test-tube open to the lumen of the colon. Stem cells near the bottom of the crypt may
be quiescent or may become active and divide to produce proliferating cells [2]. As the
proliferating cells move up the crypt they have a reduced probability of dividing and an
increased probability of differentiating [3]. In the normal colon the production of new
cells is balanced by the loss of old cells. This balance is altered in colon cancer.
Most of what we know about crypts has been obtained by experiments with mouse
tissue, rather than human tissue. This is because mouse tissue is more readily available
than human tissue, and mice can be genetically altered. Genetically engineered mice
have been a powerful tool to reveal the function of many molecules controlling intes-
tinal crypt cell proliferation, differentiation, and lineage [4]. The intestinal crypts of
mice differ from human colon crypts in several ways. Mouse crypts are smaller than
human crypts. Intestinal crypts are associated with villi, but colon crypts do not have
villi. Intestinal crypts have some cell types that are missing or not readily recognizable
in colon crypts. We have been able to obtain normal human colon biopsy tissue, and
based on measurements of the number of each cell type in multiple crypts, have for the
first time developed a calibrated model of cell dynamics in normal human colon crypts.Cell dynamics
Mathematical and computer models can incorporate features that have been observed
in static stained tissues, and by simulations, can provide insights about cell dynamics
that are not directly available from static images. The dynamics of cell proliferation in
crypts have been described by deterministic models or by stochastic models. Some
models have made use of estimates of the average number of each cell type in a typical
crypt. Deterministic models have described the numbers of each cell type, the transition
rates between cell types, the influence of one cell type on the proliferation of other cells
types, and the stability of the total number of cells per crypt [5,6]. However, we have
observed a variation in the number of each cell type in adjacent crypts in biopsies of
normal colon tissue. This variation indicates that the average number of each cell type
is not sufficient to characterize cell dynamics. This suggested to us, and others [7,8]
that the variation in numbers of cells over time, around an average, can be accounted
for by a model that incorporates a stochastic quasi-stationary process [9].
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In some previous biological descriptions of colon crypts [10,11], and in some previous
mathematical models of colon crypts [5,6] each cell is considered to have an intrinsic
type, either stem cell, proliferating cell or differentiated cell.
Stem cells are thought to be in a specialized region, the stem cell niche, in which they
respond to signals that control their maintenance and probability of division [12-19].
The molecules Dickkopf-1 (Dkk1) and the secreted frizzle related protein 1 (sFRP1) are
thought to keep quiescent stem cells in the niche from dividing [20,21]. However,
quiescent stem cells may transition to active stem cells [2]. In order to take this transi-
tion into account we have modeled the transition from quiescent stem cells to active
stem cells as the result of stem cells leaving the niche.
There is recent experimental evidence that cell types are not fixed but can interconvert
[21-26]. This has led to the concept of dynamic plasticity of cell types [27-30]. Several
published models have incorporated the concept of plasticity, in which cell types are dy-
namic and may interconvert [8,31,32]. Other mathematical models have described transi-
tions between multiple compartments of one cell type [33,34]. Many older mathematical
models of crypt dynamics have been discussed in a comprehensive review [35].
The inter-conversion of cell types may be influenced by adjacent cells and by extra-
cellular molecules, singly or in combination [36]. Measurements by gene expression
arrays and in situ hybridization indicate that there are gradients of molecules along the
crypt axis [18,37-40]. Many of these molecules have been associated with the functions
of cell proliferation and cell differentiation. Some, such as Wnt have a positive effect
[41], and others such as Dkk1 [42] have a negative effect. The model presented here
assumes that the inter-conversion of cell types can occur as a cell moves in molecular
gradients along the crypt axis.Monoclonal conversion
Monoclonal conversion refers to a crypt in which all cells are derived from a single pro-
genitor cell [3]. Monoclonal conversion could be thought of as occurring by selection
or by a random process. In the former process, only one of many possible quiescent
progenitors more efficiently begins to proliferate, or produces more rapidly dividing
progeny. In the latter process, many progenitors produce progeny clones, then without
selection there is extinction of most clones, and stochastic survival of only one clone.
The latter is referred to in population genetics as neutral drift.
Monoclonal conversion has been observed experimentally by lineage tracing in which
progenitor cells are stained and their progeny followed [43-46]. Observations and ana-
lysis of intestinal crypt stem cells and their progeny [47,48] are consistent with the con-
clusion that there is not selection of rapidly dividing progeny clones, but rather that
there is turnover of an equipotent stem cell population and that stochastically the pro-
geny of only one stem cell survives [49]. A stochastic model of proliferation of func-
tionally equivalent stem cells, rather than a master stem cell, was shown to result in
monoclonality [7,50]. A model of monoclonal conversion that couples cell cycle, cell
division, and mechanics of cell movement was used to investigate the consequences of
two different scenarios, one in which there is an intrinsically stem-like cell and the
other in which there is response of cells to the microenvironment and a population
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of colon crypt dynamics also reproduces monoclonal conversion by neutral drift.Colon cancer
Colon cancer is initiated in adenomatous crypts [52]. These crypts have an altered
morphology and an increased number of cells due to mutated cells with an increased
probability of proliferating and/or a decreased probability of dying. However, it is not
clear where in the crypt the target cells are located [53]. Wright [54] reviewed evidence
that is consistent with the initiating mutant cells being located at the bottom of the crypt
(“bottom-up” progression), and other evidence that is consistent with the initiating mu-
tant cells being located at the top of the crypt (“top-down” progression). Shih et al. [55]
reported that APC mutations, and neoplasia-associated patterns of gene expression, oc-
curred in cells at the top of crypts of small colorectal adenomas, but not in cells at the
bottom of the same crypts. Preston et al. [44] reported that monoclonal crypts (of an XO/
XY individual) did not show XY or XO adenomatous epithelium growing down into
other crypts, suggesting that the target cells for mutations were located in the stem
cell region at the base of the crypt. Zhu et al. [56] showed that Wnt activated Prom1
Lgr5 co-expressing cells stem cells developed adenomas, consistent with the idea that
neoplastic transformation can be initiated in cells at the bottom of the crypt. Barker et al.
[57] detected macroscopic adenomas developing from APC mutant Lgr5 cells located in
the stem cell region at the bottom of intestinal crypts. However, they did not detect
macroscopic adenomas from APC mutant transient amplifying cells located further up
the crypt. Together, these experimental observations suggest that mutant cells further up
the crypt may not be capable of yielding adenomas, or may do so with much less effi-
ciency than mutant cells lower in the crypt.
The possibility that mutations in differentiated migrating cells, in addition to prolifer-
ating cells, could initiate cancer was supported by the modeling results of Komarova
and Wang [58]. Komarova and Cheng [59] provided additional insight using a branch-
ing process mathematical model of crypts. They determined that the relative mutation
rates of stem cells and non-stem cells, and the relative number of each cell type affect
the probability that a crypt containing a mutant cell will progress to cancer. Mirams
et al. [60] developed a model to investigate the likelihood that the progeny of a mutated
cell will dominate a crypt taking into account cell proliferation and cell adhesion. They
concluded that it is unlikely that mutations occurring one or two cells from the base of
the crypt will become a dominant clone. Our model has allowed us to investigate the
results of locating a mutant cell at the bottom, middle or top of the crypt.Chemotherapy
Cancer chemotherapy has the goal of killing abnormal cells while sparing normal cells
in order to allow recovery of normal functioning tissue. Mouse and human crypts re-
cover from mild cytotoxic insults [61-63]. Following an exposure to a mild cytotoxic
dose of radiation, or a chemical, the number of cells per crypt in mouse tissue has been
observed to decrease, then to increase over the initial value, and finally to approach the
initial value. The level of decrease and increase, and the time required to recover, are
dose dependent [61-63]. The model we describe here displays similar kinetics of
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of different chemotherapy scheduling protocols.
Exposure to a dose that is effective against the abnormal cells while minimizing life-
threatening levels of collateral damage to normal cells might be achieved in two ways, met-
ronomics in which there is a continuous low dose for a prolonged time [64], or fractionated
doses in which there are intervals between a maximum tolerated dose to allow repopula-
tion of normal cells between doses [65]. A model in which fractionated doses allow recruit-
ment of quiescent cells into the mitotic cycle after each dose has been described [66].
Improvements in modifying dose-scheduling protocols have been mostly empirical
and slow to improve. Human-mouse xenografts and genetically engineered animals
[67,68] have been used as surrogates in order to identify differential response to inhibi-
tors of normal and cancer cells [69], and to suggest new schedules of therapeutic doses
[70]. Dose fractionation of radiation therapy [71] and dose scheduling of chemotherapy
[72] are part of standard clinical protocols. However, deviating from accepted schedules
in order to evaluate new protocols is difficult to achieve because of the many different
possible combinations of dose intensity and dose scheduling, and the ethical limitation
of experimenting on human subjects. Marcu and Harriss-Phillips [73] have reviewed
some recent mathematical and computer models of chemotherapy and radiation
therapy. Our model of human colon crypts behaves as do normal crypts; it is robust in
recovering after exposure to a cytotoxic agent. This has allowed us to investigate the
efficiency of a range of scheduling protocols that eliminate abnormal cancer cells and
allow recovery of normal crypt function.Goals of this study
There were two goals to this study. One was to develop an agent-based model that
could simulate the stochastic dynamics of each type of cell in colon crypts. These cell
types included stem cells, proliferating cells, and differentiated cells. This model was
calibrated by new measurements of cells in biopsies of normal human colon crypts.
Simulations indicted that the model had some of the emergent properties of normal
crypts, including quasi-stationary stochastic dynamics, monocolonal conversion by neu-
tral drift, formation of adenomas by mutations at the top or the bottom of the crypt,
and robust recovery from perturbation. The second goal was to provide the virtual
crypt as a tool to conduct simulation experiments in silico in order to answer questions
and gain insights that could not be addressed by observations of real human crypts in
static biopsy specimens. An example of the use of the virtual crypt is presented, viz.
different chemotherapy protocols were evaluated by simulations with a range of param-
eter values. The virtual crypt model, developed with an open source application, is be-
ing made available to other researchers to carry out further investigations.Implementation
Model description and assumptions
In agent-based models properties are assigned to each agent (biological cell) and then,
after computer simulation of repeated cell interaction, a group of cells is produced with
emergent properties (crypt) [74]. This agent-based model is in the form of an on-lattice
cellular automata model.
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death, cell movement, and cell type) are determined by a cell’s position in two gradients
along the crypt axis, a divide gradient and a die gradient. The divide gradient deter-
mines the probability that a cell will divide; the divide gradient increases from top to
bottom. The die gradient indicates the probability that a cell will die; the die gradient
decreases from top to bottom.
Cell proliferation: when a cell divides, one progeny cell is placed in the same position
as the parent cell and the other progeny cell is placed in a position to the right and
lower. Placement of one new progeny cell lower than the parent allows the crypt to in-
crease in depth. In order to make space for the this progeny cell, the adjacent cell is
pushed to the right and lower. This process is iterated. Lateral placement of one pro-
geny cell to the right or to the left, is necessary, since if successive progeny randomly
choose between left and right, then a stable crypt does not result, as can be seen in
simulations by toggling off “Polar Division”. Right, rather than left, has been chosen ar-
bitrarily. Such placement of one progeny cell laterally has been a feature of other
models [33,75]. If a new cell reaches the right edge of the roll-out image of the crypt it
will reappear on the left.
Cell movement: when a cell dies, cells below are pulled up into the empty space. This
results in cells moving up in a vertical column. Cell movement is not the result of a cell
being pushed up after cell division. This is consistent with the observations that cell
movement continues in the absence of cell division [33,76].
Cell type: a cell’s type is determined by its position in the divide gradient, Figure 1. A
progeny cell that has moved away from the position of its parent will experience aFigure 1 Cell type is determined by a cell’s position in the divide gradient. The virtual crypt is shown
on the left. Non-proliferating cells are blue, proliferating cells are red. The various cartoons of crypts on the
right illustrate the various possible locations of progeny cells after cell division at time 2, and the cell type
of the progeny. The cell type of the progeny cells is determined by their position in the divide gradient
(green triangle). Below the red line in the green triangle is the region of quiescent cells. In the top row of
cartoons, a differentiated cell (blue) at the very top of the crypt may remain undivided at time 2; or a differ-
entiated cell lower in the crypt may divide and one progeny may become a proliferative cell (red). In the
center row of cartoons, the progeny of a proliferative cell (red) that arrives low in the gradient may become
a quiescent stem cell (blue); or if it arrives high in the gradient may become a differentiated cell (red). In
the bottom row of cartoons, a quiescent stem cell (blue) may arrive in the region of proliferating cells and
become an active stem cell (red). Note the possibility of bidirectional conversion of cell types.
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phenotype than its parent. For instance, the progeny of a differentiating cell may move
down into the region of a proliferating cell and become a proliferating cell. The pro-
geny of a proliferating cell may move down into a niche region of quiescent stem cells.
In the niche it responds to a quiescent gradient, not the divide gradient. A quiescent
stem cell may, if cells above it are removed, move into the region of proliferating cells
and become an active stem cell.
Cell division and cell death are discrete events and result in a stochastic change in
the number of cells per crypt as a function of time. Such a stochastic system may be
subcritical and go extinct, or be supercritical and increase without bounds, or may be
critical and display quasi-stationary dynamics with the number of cells increasing and
decreasing about a mean value, over time. The number and variation of cells per crypt,
and the number and variation of each type of cell, measured in a series of human
crypts, suggests that biological crypts are in a critical state. One challenge of modeling
is to determine critical parameter values for which the model behaves with realistic
quasi-stationary dynamics. That is, with an average number of each cell type, and the
variation of cell types measured in real human colon crypts.Model instantiation
The crypt model was produced with the NetLogo v.4.3.3 application. NetLogo is a multi-
agent programmable modeling environment. It is authored by Uri Wilensky and devel-
oped at The Center for Connected Learning (CCL) and Computer-Based Modeling. It is a
multi-platform (Mac or Windows) open-source application available at http://ccl.north-
western.edu/netlogo/.
The virtual crypt model is included as Additional file 1. It can be run from the graphical
user interface after downloading the NetLogo application, as seen in the Additional file 2.
The model includes three parts, (1) Interface, Figure 2, (2) Information (text with modelFigure 2 Interface of the virtual crypt model implemented in the application NetLogo. The crypt
cells appear in the vertical rectangle at the left, proliferating cells in red, and non-proliferating cells in blue.
Blue boxes initiate events. Green boxes and sliders allow user to input parameter values at the interface.
Beige boxes display simulation outputs of cell numbers as dynamic plots, or single digital values of the time
when an event has occurred.
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and (3) Procedures (computer code and comments), Additional file 4.
The Interface screen, Figure 2, displays the movement of cells in a virtual crypt, and
numerical outputs. The outputs include dynamic plots of cell numbers as a function of
time and single values for the time to complete specific events. Output can also be
exported as numerical values in a spread sheet format, useful for parameter sweeps and
statistical analysis. The Interface allows a user to input different numerical parameter
values without changing the computer code.
The virtual crypt is a two dimensional “roll-out” representation of the cup-shaped
three dimensional biological crypt. The cells exist on a two-dimensional grid. The
width and height of the crypt are input using the input boxes “SetCellsPerRow” and
“RowsAtStart”. Upon activating the “Setup” and “Go” buttons, the cells appear in the
virtual crypt and respond to the divide gradient and die gradient.
Non-dividing cells appear in blue and proliferating cells appear in red. The quiescent
stem cells appear in blue at the bottom of the crypt. The proliferating cells appear in
red above the quiescent stem cells. The differentiated cells appear in blue above the
proliferating cells. The regions occupied by the quiescent stem cells, proliferating cells,
and differentiated cells are determined by values input with the “QuiesceDepth” slider,
and the “DiffCellProbabilityThreshold” input box.
After the “Go” button is pressed, the cells divide, move, and die. The number of each
cell type changes with time as each cell experiences different regions of the divide gra-
dient, and the crypt evolves. The number, as a function of time, of each cell type ap-
pears in dynamic plots.
Divide and die gradients can be viewed by turning on the toggle “ShowGradients”.
The shape of the gradients can be altered by changing the input values of the crypt
maximum, crypt minimum, and the crypt power. Other inputs allow modifying param-
eter values that affect mutations, chemotherapy, cell division orientation, crypt size,
and gradient feedback delays.
Calibration of model with measurements of biopsy
Calibration of model parameters involved three steps: (1) measurement of the number
of each of the three cell types in a series of crypts in human biopsy specimens, in order
to determine the average number of each cell type and the variation of each cell type
between different crypts; (2) parameter sweeping to determine the value for the shape
of the divide gradient and the shape of the die gradient that reproduces the measured
average number of each cell type; and (3) parameter sweeping to determine the value
for the strength of the cells’ response to the gradients that would reproduce the mea-
sured variation of each cell type.
(1)Measurement of the number of each cell type in human cryptsThree different cell types can be recognized when crypts of human biopsy
specimens are stained with an antibody to the proliferating cell antigen Ki-67,
Figure 3. Proliferating cells near the bottom one third of the crypt are stained
brown. Proliferating cells include cells that have been called active stem cells and
transient amplifying cells. Differentiated cells, which are not proliferating, located in
the top two-thirds of the crypt, are counterstained blue. Quiescent stem cells,
Figure 3 Section of biopsy of normal human colon stained brown with antibody to proliferating
antigen Ki-67, and counterstained blue with hematoxylin. Left, example of several adjacent crypts in the
tissue. Right, enlargement of a single crypt showing brown stained proliferating cells, blue stained quiescent
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Each of the three different cell types were measured in 49 crypts. This was the total
number of crypts which were available. Details of the experimental methods are
given in Additional file 5. The mean, standard deviation, and coefficient of variation
(C.V. = standard deviation/mean) are given in Table 1. The C.V. allows comparison
of the variation between different cell types with different mean values. It is note-
worthy that the C.V. of the quiescent stem cells is large, 102%, as might be expected
of a stochastic variation about a small mean.
(2)Determining the parameter values that control the shape of the divide and die
gradients in order to reproduce the average of each cell type in human crypts
The crypt gradients that affect a cell’s probability to divide or die would be expected
to influence the number of each cell type and the total number of cells in a crypt.
The shape of the divide gradient is determined by the value of the input parameter
“Crypt Divide Power”. This value can be changed by using the input box labeled
“CptDivPwr”, as shown in Figure 2. The gradient is p = y^n, where p is the
probability that a cell will divide, y equals 1 at the bottom of the bottom of the
gradient and 0 at the top, and n is the power to which y is raised. This formula
allows different shape gradients to be generated, n = 0 is no gradient, n = 1 is linear,
n > 1 is concave. The greater the value of n, the more extreme is the concavity. This
is demonstrated in the video in Additional file 6.ble 1 Measured number of each cell type per crypt
ll type Mean S.D. C.V. %
iescent stem cells 35.7 36.3 102
oliferating cells 623.9 234.1 37.5
fferentiated cells 1768.2 434.5 24.6
tal 2427.8 504.4 20.8
te: Values are for counts of 49 different crypts. Proliferating cells include transient amplifying cells and active stem
lls. S.D standard deviation, C.V coefficient of variation.
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Behavior Space function in NetLogo. A value of “Crypt Divide Power”, n = 11.5 was
chosen to simulate the observed mean number of each cell type, and mean total
number of cells. Similarly, the value of “Crypt Die Power”, n = 14 was chosen. The
probability that a cell will die is 1 at the top of the gradient, and 0 at the bottom of
the gradient. These values were used to simulate 49 different crypts, each initiated
with a different size, and allowed to run for 1000 time units.
For each cell type the observed mean values for 49 human crypts is shown in
Figure 4 together with the mean values for 49 simulated crypts. The simulated
number of each cell type is not significantly different than the observed number of
each cell type (Chi-squared test, p >0.05). This suggests that the model, with
appropriate parameter values for the gradients, produces “virtual crypts” that
resemble observed human crypts, for the average number of each cell type, and for
the average total number of cells.
(3)Determining the parameter values of each cell’s response the gradients in order to
reproduce the variation in numbers of each cell type in human crypts
The number of each kind of cell in a biological crypt would be expected to vary
with time with quasi-stationary dynamics, i.e. varying in time stochastically about
an average value. The variation of a single crypt over time can be inferred from the
measurements of the variation of multiple human crypts at a single time.
The values chosen for the divide gradient and die gradient were adequate to
simulate the measured average number of each cell type and the measured average
total number of cells per crypt. However, these values were not adequate to
simulate the measured variation in the number of each cell type and the measured
variation in the total number of cells per crypt. For instance, whereas the measured
C.V. of the total number of cells was 20.8%, the simulated C.V. was only 3.3%.
There was also a difference between the measured and simulated C.V. for each cellFigure 4 Comparison of the observed (Obs) mean number of each cell type and mean number of
total cells per crypt measured in 49 crypts, with the simulated (Sim) numbers. Diff = differentiated
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the stimulated C.V. was only 44.3%.
Quiescent stem cells that move out of the their niche can become active stem cells.
Active stem cells above the niche are in gradient values that determine a high
probability of dividing. Some of the progeny of active stem cells may move back
down into the niche and become quiescent stem cells. Therefore, the number of
quiescent stem cells could vary stochastically over time. The quiescent stem cell
population with the large variation of 102% and small average number of 35.7 has a
danger of going extinct. However, extinction might be avoided if the rate of change
in cell type is influenced by feedback, a delay in a cell’s response to the value of the
gradient in which it is relocated.
In this model a cell that moves to a new position in the divide gradient will acquire a
new probability of dividing immediately if the gradient feedback strength = 1. If the
gradient feedback strength <1, the cell will acquire a new probability of dividing, at
each time unit, that is intermediate between its probability of dividing at its old
position and its new position. This will result in a delay in responding the gradient. If
the gradient feedback strength = 0, the cell will not respond to the gradient in its new
position and retain the probability of dividing that it had before it moved.
The effect of gradient feedback strength on the average number of quiescent stem
cells was determined for a range of gradient feedback strengths, Figure 5. With a
gradient feedback strength = 1 (no delay in responding the gradient) the simulated
average number of quiescent stem cells is greater than the measured value. With a
gradient feedback strength = 0.1 (a modest delay in responding to gradient) the
simulated average number of quiescent stem cells is similar to the measured
average number of quiescent stem cells. And notably, the simulated coefficient of
variation of the number of quiescent stem cells is similar to the observed value,ure 5 Effect of the quiescent gradient feedback strength on the number of simulated quiescent
cells (SCq). Gradient feedback strength = 1 produces an immediate response, gradient feedback
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niche, into the region of the proliferating cells, will respond to the gradients with
some delay before become active stem cells.
Proliferating cells and differentiated cells also respond to their relocated position in
the divide gradient with a feedback delay. The observed coefficient of variation of
each cell type, can be simulated with delayed response to the gradient, Figure 6.
This is accomplished by setting their gradient feedback strengths < 1. Since a delay
is required to simulate the measured variation in the total number of cells per crypt
and the measured variation in the number of each cell type, these results suggest
that proliferating and differentiated biological cells may also respond to the
gradients with a delay.Verification of model behavior
The behavior of the calibrated crypt model was verified by its ability to simulate
three emergent properties observed in biological crypts, (1) monoclonal conversion
by neutral drift, (2) adenoma formation by mutants at different locations, and (3) robust
recovery from exposure to a cytotoxic agent.
(1)Virtual crypts undergo monoclonal conversion by neutral driftCrypts can undergo monoclonal conversion, in which all cells in the crypt are the
product of a single cell. Monoclonal conversion may be the result of one stem cell
producing progeny that outcompete the progeny of other stem cells; or may be the
result of only one stem cell at a time producing progeny [77]. Experimental
observations are consistent with neutral drift in which the progeny of only one
stem cell survive, without the need for a proliferative advantage of the progeny of
that stem cell [47,48].
Monoclonal conversion was visualized in the virtual crypt by switching on the
toggle “ViewProgeny”. No cells were given an proliferative advantage. Initially,ure 6 Comparison of the observed (Obs) and simulated (Sim) coefficient of variation of number
ach cell type, and coefficient of variation of number of total cells per crypt. Diff = differentiated
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a single color, the progeny of one cell. This can be seen in Additional file 7. Each
repeat of the experiment generates a crypt of a different color and a different time
to achieve monoclonality. The distribution of times are approximately log normal
with a mean of 2633 time units and standard deviation of 1610. These simulation
results indicate that the virtual crypt behaves similarly to biological crypts, i.e. they
undergo monoclonal conversion by neutral drift, and that selection is not necessary.
(2)Virtual crypts initiate adenomas by both “top-down” and “bottom-up” mutations
Abnormal proliferation of cells in crypts can lead to colorectal adenomas, crypts with
more cells than normal. Some observations have been interpreted as suggesting that
the mutant progenitor cells are located at the top of the crypt resulting in “top-down”
morphogenesis [55]. Other observations have been interpreted as suggesting that the
progenitor cells are located at the bottom of the crypt resulting in “bottom-up”
morphogenesis [44]. The virtual crypt was used to investigate the effects of placing
mutant progenitor cells at different positions in the crypt. Mutant cells were generated
with a 1.3× greater probability of dividing than normal cells, and with a 1.1× greater
probability of dying. The efficiency of forming adenomas, considered as crypts that
have 40% more cells than normal, was determined.
The results in Table 2 indicate that adenomas can be formed by mutant cells
initially located in each of several different regions of the crypt. Mutant cells placed
at the bottom of the crypt in the region of quiescent stem cells, or placed about 1/3
up from the bottom of the crypt in the region of proliferating cells, or placed about
1/3 from the top of the crypt in the region of the differentiated cells, each formed
adenomas, but with different efficiencies. These results suggest that both “top-
down” and “bottom-up” morphogenesis may occur, but that “bottom-up” is more
efficient. The most efficient location is within the lower region of proliferating cells.
This would be expected to include active stem cells. These simulation results
indicate that virtual crypts behave similarly to biological crypts, i.e. they can form
adenomas from mutant cells located at the top or the bottom of the crypt.
(3)Virtual crypts are robust and recover after a cytotoxic dose of chemotherapy
Crypts have been reported to recover from cytotoxic chemotherapeutic drugs and
ionizing radiation in a dose dependent manner. After a single dose to mice the total
number of cells per crypt decreases, overshoots the initial value, and then returns
to the initial value, with the rate of recovery dependent on dose [61]. In order to
determine if the virtual crypt was similarly robust in response to cytotoxic
perturbation, a virtual crypt was exposed to a single dose and the total number of
cells per crypt was followed as a function of time.
The probability that a cell in a virtual crypt will die after cytotoxic chemotherapy is
its probability of dividing before chemotherapy times the “Lethality” of the dose,ble 2 Top-down and bottom-up mutations each produce adenomas
sition of mutation (cell rows from top) Mutant cell type Efficiency %
p third (20) Differentiated cell 8.5
wer third (59) Proliferating cell 85
ttom (65) Quiescent stem cell 57
te: Efficiency is the percent of 200 crypts that achieved a size 40% larger than normal crypts in 500 time units.
Fig
at t
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http://www.tbiomed.com/content/10/1/66i.e. more rapidly dividing cells are more sensitive to a specific cytotoxic dose.
Virtual crypts were exposed to a “Lethality” of 5 or 320, and the total number of
cells per crypt was determined as a function of time, Figure 7. The virtual crypts
recover with kinetics similar to those that have been reported for biological crypts,
the total number of cells decreases, overshoots the initial value, and then returns to
the initial value. In addition, there is a dose dependent minimum number of cells,
maximum number of cells, and time to recovery. These simulation results indicate
that the virtual crypts are robust, and that they behave similar to biological crypts
in their response to a cytotoxic agent, both in kinetics and in a dose dependent
manner.
Because the calibrated virtual crypts recovered from cytotoxic doses they could be
to be used to simulated cancer chemotherapy and to explore the effectiveness of
different dose schedules.ure 7 Recovery of virtual crypts after cytotoxic therapy. Crypts with about 2400 cells were exposed
ime 500 to a low dose of cytotoxic therapy (A), or high dose of cytotoxic therapy (B).
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In order for a computer model to be useful as an informative simulation tool it needs
to be calibrated to the real system that it intends to simulate, shown to reproduce the
behavior of the real system, and accessible as a tool to simulate new scenarios and pro-
duce interpretable quantitative results. This section provides an example that shows
that the virtual crypt model satisfies the third criterion, i.e. that it can be used to simu-
late a range of chemotherapy scenarios and can produce informative results.
A desired chemotherapy protocol might be one that (1) removes all tumor cells, (2) uses
a minimum duration of exposure to chemotherapy, and (3) simultaneously minimizes col-
lateral damage to healthy non-tumor cells. The model was used to determine the effect of
a range of parameter values. Several parameters of chemotherapy can be modified from
the graphical user interface. These include, the Lethality (increased probability of dying),
Duration (time period of exposure), and Interval (period between the beginning of one
period of exposure and the beginning of the next). Fractionated chemotherapy, that
allowed recovery between doses, was simulated in order to answer the question “What
duration of chemotherapy would be optimal?”
Mutant tumor cells were simulated by adding 0.16 to their probability of proliferating,
and adding 0.1 to their probability of dying. They were placed in the lower third of the
crypt and allowed to proliferate to form an adenoma, Additional file 8. When the number
of mutant tumor cells reached 50% of the total cells in the crypt, a low dose of chemother-
apy was applied, Lethality = 2. The Intervals between doses were fixed at 8× the Duration
of doses. For a range of chemotherapy Durations, the time to eliminate all mutant tumor
cells (Time to Cure) is shown in Figure 8, A; and the collateral damage to healthy cells is
shown in Figure 8, B. The longer the Duration of chemotherapy the shorter the time to
eliminate all mutant tumor cells (Time to Cure). However, a longer Duration of chemo-
therapy also increases the collateral damage to healthy cells. Comparison of the two
graphs suggests that a Duration of chemotherapy of 3 time units would be an optimum
trade off. This Duration of exposure to chemotherapy would be sufficient to eliminate all
tumor cells while minimizing collateral damage to healthy cells. A longer Duration of ex-
posure to chemotherapy would have about the same time to cure, but would increase the
collateral damage to healthy cells. The simulated kinetics of mutant cell death and normal
crypt recovery during chemotherapy are shown in the video in Additional file 9.
These simulation results indicate that the robust virtual crypt model can be used for
in silico experiments to investigate different chemotherapy scheduling protocols and
produce quantitative results. The relationship between the range of Duration times and
the balance between time to cure and collateral damage to healthy cells would not be
easily obtained by other means.Discussion
The model presented here was developed to simulate the stochastic cell dynamics in
crypts of the human colon. It took into account recent evidence that cell types are plas-
tic, i.e. that there can be inter-conversion between cell types. The model is the first to
reproduce the average number of each cell type (stem cells, proliferating cells, and dif-
ferentiated cells) and the variation of each cell type, measured in human colon crypts.
It also reproduced the behavior of biological crypts, including monoclonal conversion
Figure 8 Simulation of chemotherapy protocols. The effects of different durations of chemotherapy on
time to eliminate all tumor cells (A), and the collateral damage to healthy cells (B). A duration of
chemotherapy of 3 time units eliminates all tumor cells while minimizing collateral damage to healthy cells.
Each Duration time unit is 4.5 hr.
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along the crypt axis, and robust recovery after exposure to a cytotoxic agent. The utility
of the model was demonstrated by experiments conducted at the graphical-user inter-
face that explored the effect of a range of parameter values for chemotherapy.Inter-conversion of cell types
In this agent-base model, progeny cell types are determined not by the type of their
parent, but rather by their position in a divide gradient along the crypt axis. The divide
gradient has a low value at the top of the crypt and a higher value toward the bottom
of the crypt. A progeny cell that moves to a new position away from a parent has a type
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parent, Figure 1. The value of a gradient at a cell’s position along the axis of the crypt
depends upon the length of the gradient, that is, the total number of cells in the crypt.
As the total number of cells stochastically increases by division or decreases by cell
death, the value of the gradient at a position may change. A progeny cell may arrive in
a higher or lower gradient value than its parent. As a consequence, the change in cell
type from parent to progeny is not limited to a change in one direction, but may be bi-
directional. For instance, a proliferating cell may produce one or more progeny cells
that are also proliferating cells, or one or more progeny cells that are differentiated
cells, or one or more cells that are quiescent stem cells. Similarly quiescent stem cells
may produce proliferating cells; and the reverse, proliferating cells may produce quies-
cent stem cells.The divide gradient
After cell division, a progeny cell’s type will depend on its response to the value of the
divide gradient at its new position. In this model the response is determined by the
“Gradient feedback strength”. It is the response of a progeny cell to the difference in
the gradient value at its new position compared to the old position of its parent. The
strength of the response affects the variation of cell numbers over time. Parameter
sweeping was used to determine value of the “Gradient feedback strength” that repro-
duced the observed coefficient of variation between crypts, Figure 6.
The divide gradient may be determined by the concentration of a ligand along the
crypt axis. The response to the divide gradient may be influenced by the number of
receptors on the cell, as well as the time period required for signal transduction, gene
expression, protein synthesis, protein processing, and protein translocation to the cell
surface. These, in turn, may depend on the rate of progression through the cell cycle.
Molecules with gradients along the crypt axis have been described [18,37-39]. Some of
these molecules have been the basis of other crypt models. These molecules include
Wnt [78], Wnt and Notch [8,32], and EphB receptors and ephrinB ligands [79]. Our
model is agnostic as to the identification of the molecule, or combination of molecules,
that might be responsible for the divide gradient and the cell’s response to the gradient.The die gradient
Homeostasis requires that cells be removed as new cells are produced. The die gradient
along the crypt axis indicates the probability that a cell will die, and be removed. There
is a greater probability that a cell will be removed at the top than at the bottom. The
consequence of a cell near the top being removed is that a cell below it can move up
into its former position. This process can be iterated, resulting in cells moving up the
crypt in a column. Kaur and Potten [76] observed that cell migration occurred after re-
covery from radiation, hydroxyurea, or other cytotoxic agents, even in the absence of
mitotic activity. This is consistent with cell movement resulting from cells being pulled
up from the top, rather then being pushed up from the bottom. It is not clear what is
the mechanism of cell removal. Apoptosis, and removal of dead cells by macrophages,
is most frequent at the top [80]. Cell removal may be a response to the curvature of
the cell layer at the lumen, as seen in Figure 2. This could result in removal of densely
Bravo and Axelrod Theoretical Biology and Medical Modelling 2013, 10:66 Page 18 of 24
http://www.tbiomed.com/content/10/1/66packed cells and death by anoikis [81]. However, exfoliation, common in neoplasia, has
been reported to be rare in normal human colon crypts [82]. Alternatively, the die
gradient may be the result of a cell division counting mechanism, such as loss of telo-
meres [22]. This model does not invoke a specific mechanism for cell death and cell
loss.Stem cells
We measured an average of 35.7 quiescent stem cells per human colon crypt. This was
determined as the number of cells in the bottom of the crypt that did not stain with
the antibody to Ki-67, a protein that is expressed in proliferating cells [83]. Other inves-
tigators have identified quiescent stem cells, active stem cells, or stem cell precursors,
as cells at or near the bottom of the crypt that uniquely express specific proteins. These
proteins include Lgr5 [84], Bmi1 [85], musashi-1 [86,87], aldehyde dehydrogenase 1
[88], and Lrg1 [89]. Stem cells have also been recognized by utilizing functional assays
[29,90] or by linear tracing [45]. Potten et al. [91] measured the number of clonogenic
cells after radiation in the small intestine of mice and concluded that there were about
32 “functional” stem cells. Loeffer et al. [33] developed a model of steady-state prolifer-
ation in mouse intestine crypts and by fitting successive labeling index data concluded
that there are more than 4 and more likely closer to 16 stem cells per crypt. Kozar
et al. [92] calculated the number of stem cells per crypt in the mouse small intestine as
5–6, and in the colon as 7, by lineage tracing of crypts with spontaneous mutations in
[CA] 30 repeats. Nicolas et al. [93] analyzed methylation patterns of human colon crypts
and concluded that there was a modal value of between 15 and 20 stem cells per human
colon crypt.
The differences in the estimates of the number of stem cells per crypt may be due to
several factors, including differences in the types of cells that are detected by different
assays, i.e. quiescent stem cell, active stem cells, or stem cell precursors. Other contrib-
uting factors include differences in the size of mouse and human crypts, and differences
in size of crypts in the intestine and in the colon.
We measured the variation of the number of quiescent stem cells in adjacent crypts
in a fixed biopsy specimen and found a large coefficient of variation, 102%. This vari-
ation in different crypts at one time suggests that the number of quiescent stem cells in
any one crypt is dynamic and varies over time [94]. Our model reproduces this vari-
ation of the number of stem cells. It also reproduces the variation of each of the other
cell types measured in human crypts. This was achieved by determining appropriate
values for the strength of feedback response of cells to their gradients. Feedbacks have
been included in other models of the dynamics of crypts [5,32,95,96] and other similar
structures [31,97]. These models have included feedbacks in order to simulate an aver-
age number of cells over time, whereas in our model feedbacks were included in order
to simulate the variation in number of cells over time.The virtual crypt is robust to perturbation
The virtual crypt is robust, as are biological crypts, in recovering after exposure to a
cytotoxic agent, Figure 7. When unperturbed, the number of cells per crypt is in a
quasi-stationary state. After a crypt is exposed to a cytotoxic dose there is a reduction
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more sensitive than the quiescent cells which are non-dividing and the differentiated
cells which have a low probability of dividing. The reduction in the total number of
cells has the effect of quiescent stem cells arriving within the region of the divide gradi-
ent. This results in them having a greater probability of dividing. The former quiescent
stem cells convert to become active stem cells and their progeny become proliferating
cells. The result is that the total number of cells increases briefly until the quasi-
stationary state is restored. Similar recovery behavior has been achieved in other crypt
models [8,98].The virtual crypt model was used to investigate chemotherapy protocols
Since the virtual crypt recovers after exposure to cytotoxic agents, it can be used to
simulate chemotherapy, or radiation therapy, with different scheduling protocols. Dif-
ferences in the interval between cytotoxic doses, the duration of the doses, and the
lethality of each dose can be varied at the graphical user interface. In one example, par-
ameter sweeping was used to determine the optimum duration of chemotherapy that
would eliminate all mutant tumor cells with the minimum collateral damage to healthy
cells, Figure 8. The response of the virtual crypt to chemotherapy as a function of time
can be seen in the video demonstration provided in Additional file 9.
There are limitations in translating the results of simulating cancer chemotherapy
protocols. It would be necessary to determine the difference in the rates of cell prolifer-
ation, cell death, and cell differentiation of the mutant cells from those of normal cells.
Proliferation and death rates are routinely measured in cell culture, albeit not in tissue
context. Cell differentiation rates can be measured by utilizing the proportion of clonal
populations that stain positively for expression for protein markers of differentiation
[99]. More stringent limitations are that the model does not yet take into account
angiogenesis, invasion, and the effect of cytotoxicity on other tissues such as bone
marrow or heart. Although no model is complete, this model and other in silico
models, have provided insights that are not readily available by other means [73].Additional applications of the virtual crypt model
One of the goals of this project was to provide a tool that would facilitate in silico ex-
periments. Several examples of experiments using the virtual crypt model have been
described in the sections “Verification of model behavior”, and “Results”. The model of
the virtual crypt is being made available for other users to conduct additional in silico
experiments, Additional file 1. The experiments can be conducted by inputting single
parameter values at the graphical user interface and seeing the output plots in real
time, or by conducting parameter sweeps using the Behavior Space tool and collecting
numerical data in table or spreadsheet format for statistical analysis. Some example
additional experiments include the following:
Modeling crypts of other organisms
The model described here was calibrated with measurements of the number of cells in
a human biopsy. Crypts of other organisms, such as the mouse for which there is a
large amount of experimental evidence, could be modeled by turning on the
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the “CellTarget” box.
Investigating non-homeostatic conditions
Parameter values were determined that allowed the virtual crypt to be in a critical state,
i.e. to maintain quasi-stationary numbers of each cell type over time. However, a sto-
chastic process may be critical, subcritical, or supercritical depending on the ratio of
cell birth and cell death. This ratio may be altered by mutation, cytotoxic therapy, or
redistribution of growth factors. The result could be crypts becoming either extinct or
unbounded in cell number. The reporter box “ExtinctionTime” will display the time
when a crypt becomes extinct, and the reporter box “UnboundedSizeTime” will display
the time when a crypt becomes unbounded in cell number. Multiple runs using the
Behavior Space tool can provide information on the distribution of times for such events,
and the range of parameters for which the crypt is critical, subcritical, or supercritical.
Exploring modes of therapy
Fractional chemotherapy was described as an application of the crypt model. In frac-
tional chemotherapy there is a repeated application of a maximum tolerated dose of a
cytotoxic agent for fixed duration, interspersed with a period of no exposure to the
agent to allow recovery. Other kinds of therapy can be explored with the virtual crypt
model. For instance, in metronomic chemotherapy there is application of a continuous
low dose of an agent [64]. The results of metronomic therapy can be modeled by set-
ting the value of chemotherapy “Interval” and “Duration” to be equal, so that there will
be no gap in time between doses. Then the intensity and period of therapy to achieve
cure (zero “Proportion Mutant Cells”) can be determined by parameter sweeping the
values of “Duration” and “Lethality”. Another the kind of therapy, differentiation ther-
apy, aims not to kill mutant proliferating cancer cells with a cytotoxic agent, but rather
to induce them to differentiate into more normal cells that will undergo terminal differ-
entiation and therefore not continuing to proliferate. Differentiation therapy has been
successfully applied to leukemia cells [100] and has been suggested for solid tumors
[101]. Differentiation therapy can be simulated by changing the “Crypt Divide Max”,
and then using parameter sweeping with the Behavior Space tool to determine the
values of other parameters that maintain homoeostasis of numbers of crypt cell types.
An important consideration of any therapy is the existence of heterogeneity of pheno-
types among cells in the tumor population [102]. Heterogeneity could be accounted for
in the virtual crypt model by simulating different mutant cell phenotypes, and doing
parameter sweeping for each phenotype to determine which range of values of “Interval”,
“Duration”, and “Lethality” are effective for each different mutant phenotype. Then, a
range of parameter values can be chosen that are effective for all, or most, of the different
mutant cell phenotypes.Conclusion
An agent-based model of homeostatic cell dynamics of human colon crypts has been
developed. It was verified as behaving similarly to real crypts, in that it undergoes
monoclonal conversion by neutral drift, forms adenomas by mutations located at the
top and the bottom of the crypt, and is robust in recovering from cytotoxic perturb-
ation. This model has several novel features. It reproduces the average number of each
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stationary stochastic cell dynamics of human crypts as deduced from the measured
variation of cell types between different human crypts. Also, it facilitates in silico exper-
iments at the graphical user interface.
Model availability and requirements
Additional file 1 includes the complete model for the virtual crypt, including the “Interface”
section, “Information” section (text description), and “Procedures” section (com-
puter scripts). It is licensed under GNU GPL 3. The model runs on the NetLogo ap-
plication. NetLogo is a multi-agent programmable modeling environment that runs
on Windows PC and Mac platforms. It is an open-source application available at
http://ccl.northwestern.edu/netlogo. It is authored by Uri Wilensky and developed at
The Center for Connected Learning (CCL) and Computer-Based Modeling.
Additional files
Additional file 1: Virtual crypt model. The model runs on the open-source multi-platform NetLogo application
available at http://ccl.northwestern.edu/netlogo/.
Additional file 2: Implementation of the virtual cyrpt (20.5 MB). Video and audio. QuickTime Player for PC
and Mac is available as free download, www.apple.com/quicktime/download/.
Additional file 3: Information. Includes text that describes how to initiate running the model from the Interface.
Describes each of the inputs (buttons, sliders, boxes, and outputs (plots, and boxes) of the interface of the model.
Includes criteria for selecting default values, and how to conduct parameter sweeps.
Additional file 4: Procedures. Includes computer script and comments for the model.
Additional file 5: Experimental methods. Includes source of specimen, image acquisition, measurement by
image analysis, and determination of reliability of measurements.
Additional file 6: Cell numbers of the virtual crypt (18.1 MB). Video and audio. QuickTime Player for PC and
Mac is available as free download, www.apple.com/quicktime/download/.
Additional file 7: Monoclonal conversion (18.6 MB). Video and audio. QuickTime Player for PC and Mac is
available as free download, www.apple.com/quicktime/download/.
Additional file 8: Induction of adenoma (12.5 MB). Video and audio. QuickTime Player for PC and Mac is
available as free download, www.apple.com/quicktime/download/.
Additional file 9: Cancer chemotherapy (14.9 MB). Video and audio. QuickTime Player for PC and Mac is
available as free download, www.apple.com/quicktime/download/.
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